Press Release: Array BioPharma : Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2019
BOULDER, Colo., Feb. 5, 2019 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today reported results for its second quarter of fiscal 2019 and provided an update on the progress of its key commercial products and clinical development programs.
Read full article »
CEO
Array is a biopharmaceutical company that researches, develops and commercializes targeted small molecule medicines to treat cancer.
Read more